In this study, we also identified that CLL cells obtained at the time of progression had enhanced capacity of inducing exhaustion in both autologous and HD-derived CD8+ T cells compared to malignant CLL cells from patients with stable disease, as well as increased capacity to secrete IL-10 upon microenvironmental stimuli. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.